Related Articles
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
In this photo illustration, Pfizer’s Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. Joe Raedle | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support the drug’s use in adults at high risk of progressing to severe disease. The […]
Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general population
Pfizer and BioNTech said Monday they have submitted early stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine booster for everyone 16 and older — not just people with weak immune systems. In a phase one trial, a booster dose of the […]
3 takeaways from the Investing Club’s ‘Morning Meeting’ on Monday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Nvidia’s warning is a reset The bad news didn’t tank the market The Inflation Reduction Act could be bad for the market 1. Nvidia’s warning is a reset Nvidia (NVDA) […]